Gardasil: Blood clots, fainting, and shady marketing
New studies reported in the Journal of the American Medical Association provide even more reasons why we should keep Gardasil far, far away from our daughters.
The CDC and FDA recently proclaimed that the side effects of the HPV vaccine Gardasil are about what they expected. Adverse effects (including 32 DEATHS), they say, are right in line with other vaccines. So I guess we should all stop worrying so much, since this particular vaccine is only killing the same number of people other vaccines do.
Is it just me, or is there a flaw in the logic there?
And what about the disproportionately high rates of fainting and blood clots reported in the August 18 issue Journal of the American Medical Association? And the accompanying editorial that says the vaccine’s benefit to women is “uncertain.”
I guess we’re supposed to just ignore all of that, too.
Sorry—not when we’re talking about the well-being of countless young women.
And we’re not going to ignore the other study in the same issue of JAMA—the one that calls out the shady marketing practices used to push the vaccine. Medical associations accepting Big Pharma money for “educational campaigns,” unbalanced information on risks vs. benefits, securing mandates that schools require the vaccine—if the article in JAMA is to be believed, Merck & Co. has some pretty shameful actions to answer for.
Especially when you consider a shocking fact pointed out by Diane Harper, MD, of the University of Missouri Kansas City School of Medicine. The incidence rate of cervical cancer in the United States is actually LOWER than the incidence of adverse effects from the very vaccine that’s supposed to protect against it—3.0 per 100,000 women vs. 4.3 per 100,000 doses.
And that’s based on distributed doses—not on what’s actually been used—so the number of adverse effects could be much, much higher.
“HPV Vaccine Side Effects As Expected,” MedPage Today (www.medpagetoday.com).